Relay Therapeutics, Inc.
NASDAQ:RLAY
3.81 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 143.736 | 998.917 | 958.073 | 447.646 | 41.954 | 421.505 |
| Short Term Investments
| 606.35 | 847.123 | 677.954 | 230.415 | 313.862 | 0 |
| Cash and Short Term Investments
| 750.086 | 998.917 | 958.073 | 678.061 | 355.816 | 421.505 |
| Net Receivables
| 0 | 5.219 | 4.94 | 82.654 | 0 | 0 |
| Inventory
| 0 | 12.11 | -682.491 | -238.069 | 0 | 0 |
| Other Current Assets
| 20.017 | 15.369 | 13.229 | 9.385 | 4.72 | 2.597 |
| Total Current Assets
| 770.103 | 1,019.505 | 976.242 | 770.1 | 360.536 | 424.102 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 68.87 | 75.388 | 27.323 | 28.829 | 31.654 | 3.631 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 2.3 | 2.3 | 2.3 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 2.3 | 2.3 | 2.3 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 2.578 | 2.578 | 0.878 | 0.878 | 0.878 |
| Tax Assets
| 0 | -2.578 | -2.578 | 0 | 0 | 0 |
| Other Non-Current Assets
| 2.707 | 2.578 | 2.578 | 0.022 | 0 | 0 |
| Total Non-Current Assets
| 73.877 | 80.266 | 32.201 | 29.729 | 32.532 | 4.509 |
| Total Assets
| 843.98 | 1,099.771 | 1,008.443 | 799.829 | 393.068 | 428.611 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 9.211 | 10.578 | 8.276 | 6.351 | 6.991 | 4.705 |
| Short Term Debt
| 4.964 | 8.552 | 3.688 | 3.042 | 1.249 | 0.178 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0.248 | 5.563 | 3.413 | 1.864 |
| Other Current Liabilities
| 16.094 | 44.579 | 12.109 | 4.239 | 3.746 | 1.982 |
| Total Current Liabilities
| 30.269 | 63.709 | 24.321 | 13.632 | 11.986 | 6.865 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 48.502 | 53.466 | 21.056 | 22.901 | 23.583 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 13.206 | 32.378 | 65.258 | 0.003 | 537.937 | 532.673 |
| Total Non-Current Liabilities
| 61.708 | 85.844 | 86.314 | 22.904 | 561.52 | 532.673 |
| Total Liabilities
| 91.977 | 149.553 | 110.635 | 36.536 | 573.506 | 539.538 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 799.829 | 537.781 | 532.12 |
| Common Stock
| 0.127 | 0.121 | 0.109 | 0.09 | 0.004 | 0.003 |
| Retained Earnings
| -1,400.582 | -1,058.609 | -768.1 | -404.228 | -189.482 | -114.177 |
| Accumulated Other Comprehensive Income/Loss
| -0.196 | -10.42 | -1.088 | 0.064 | 0.325 | -4.649 |
| Other Total Stockholders Equity
| 2,152.654 | 2,019.126 | 1,666.887 | 1,167.367 | 8.715 | 7.896 |
| Total Shareholders Equity
| 752.003 | 950.218 | 897.808 | 763.293 | -180.438 | -110.927 |
| Total Equity
| 752.003 | 950.218 | 897.808 | 763.293 | -180.438 | -110.927 |
| Total Liabilities & Shareholders Equity
| 843.98 | 1,099.771 | 1,008.443 | 799.829 | 393.068 | 428.611 |